Retro Biosciences

In a new documentary with ABC, Retro CEO @BettsLaCroix shares Retro’s mission of adding 10 healthy years to the human lifespan.

He explains the science behind that goal to reporter @NormanSwan, including Retro's work on autophagy, the process cells use to clear out damaged material as they age. That program is now in a Phase 1 clinical trial for Alzheimer’s disease.

Watch the full documentary: youtube.com/watch?v=77TTDk…

Recently, joe sat down with @juliankissa of The Beyond Tomorrow Podcast to talk about using AI to engineer better proteins, going upstream to treat Alzheimer's, and why biological timescales are the one thing you can't accelerate. youtu.be/x0J437kmXNA

We're announcing the initial close of our next financing round at a $1.8B pre-money valuation. retro.bio/blog/fundraise…

We set out to reach the clinic in Q4, and we delivered.

With our First In Human milestone achieved, Retro officially becomes a clinical stage company.

Deep thanks to the teams who made this possible. We are excited for what 2026 will bring.

corememory.com/p/exclusive-re…

read more about our collaboration with @OpenAI on using gpt-4b for protein engineering of reprogramming factors